Investment Summary

Simulations Plus Invests In Nurocor

On July 14, 2025, Simulations Plus invested in software company Nurocor

Investment Highlights
  • This is Simulations Plus’ 4th transaction in the Software sector.
  • This is Simulations Plus’ 4th transaction in the United States.
  • This is Simulations Plus’ 1st transaction in Texas.

Investment Summary

Date 2025-07-14
Target Nurocor
Sector Software
Investor(s) Simulations Plus
Deal Type Stake Purchase

Target

Nurocor

Austin, Texas, United States
Nurocor offers a cloud-based software platform designed to improve efficiency, reusability, governance, and automation for pharmaceutical companies through digitalization in the clinical development phase. Nurocor was founded in 2017 and is based in Austin, Texas.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Simulations Plus

Lancaster, California, United States

Category Company
Founded 1996
Sector Software
Employees243
Revenue 70M USD (2024)
DESCRIPTION

Simulations Plus is a provider of software services to pharmaceutical and biotechnology, industrial chemical, cosmetic, herbicide, and food ingredient industries. Simulations Plus was founded in 1996 and is based in Lancaster, California.


DEAL STATS #
Overall 5 of 5
Sector: Software M&A 4 of 4
Type: Stake Purchase M&A Deals 1 of 1
State: Texas M&A 1 of 1
Country: United States M&A 4 of 4
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-06-12 Pro-ficiency

Raleigh, North Carolina, United States

Pro-ficiency is an eLearning provider of tech-enabled training and compliance solutions for clinical trials. The Company provides a comprehensive suite of services, including a turn-key offering of customized, virtual training simulations, training, and compliance monitoring tools, and real-time data & predictive analytics. Pro-ficiency was founded in 2014 and is based in Raleigh, North Carolina.

Buy $100M